IND-Enabling Studies for Gene Therapy for Glaucoma
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Diorasis Therapeutics, Inc.
Award Date
Award Amount
650,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Remis Bistras
Fiscal Year
2026
Region
Research Triangle
Project Description:
Diorasis Therapeutics of Durham received $650,000 to advance their gene therapy for glaucoma through IND-enabling studies.